Registration Statement under the Securities Act of 1933 |
☒ |
Pre-Effective Amendment No. |
☐ |
Post-Effective Amendment No. |
☐ |
and/or |
|
Registration Statement under the Investment Company Act of 1940 |
☒ |
Amendment No. 11 |
☒ |
Julien Bourgeois Dechert LLP 1900 K Street, N.W. Washington, DC 20006 |
Allison Fumai Dechert LLP 1095 Avenue of the Americas New York, NY 10036 |
☐ |
Check box if the only securities being registered on this Form are being offered pursuant to dividend or interest
reinvestment plans. |
☒ |
Check box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance
on Rule 415 under the Securities Act of 1933 (“Securities Act”), other
than securities offered in connection with a dividend reinvestment
plan. |
☒ |
Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment
thereto. |
☐ |
Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment
thereto that will become effective upon filing with the Commission pursuant to
Rule 462(e) under the Securities Act. |
☐ |
Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction
B to register additional securities or additional classes of securities pursuant to
Rule 413(b) under the Securities Act. |
☐ |
when declared effective pursuant to section 8(c) of the Securities Act |
☒ |
Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (the
“Investment Company Act”)). |
☐ |
Business Development Company (closed-end company that intends or has elected to be regulated as a business
development company under the Investment Company Act. |
☐ |
Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase
offers under Rule 23c-3 under the Investment Company Act). |
☒ |
A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). |
☐ |
Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). |
☐ |
Emerging Growth Company (as defined by Rule 12b-2 under the Securities and Exchange Act of 1934). |
☐ |
If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities
Act. |
☐ |
New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months
preceding this filing). |
|
Page |
5 | |
10 | |
12 | |
14 | |
14 | |
14 | |
14 | |
15 | |
17 | |
26 | |
30 | |
30 | |
32 | |
35 | |
36 | |
36 | |
38 | |
38 | |
39 | |
39 | |
43 | |
45 | |
45 | |
45 | |
45 | |
45 | |
46 |
The Trust |
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust (the “Trust”) is a
diversified, closed-end management investment company. |
The Offering |
The Trust may offer, from time to time, up to $[•] aggregate initial offering price of Common
Shares, on terms to be determined at the time of the offering. The Trust will offer Common
Shares at prices and on terms to be set forth in one or more supplements to
this Prospectus (each, a “Prospectus Supplement”).
|
|
The Trust may offer Common Shares (1) directly to one or more purchasers, (2) through
agents that the Trust may designate from time to time, or (3) to or through underwriters or
dealers. The Prospectus Supplement relating to a particular offering will
identify any agents or underwriters involved in the sale of Common Shares,
and will set forth any applicable purchase price, fee, commission or discount
arrangement between the Trust and agents or underwriters or among
underwriters or the basis upon which such amount may be calculated. The Trust
may not sell Common Shares through agents, underwriters or dealers without
delivery of this Prospectus and a Prospectus Supplement describing the method and terms of
the offering of Common Shares. See “Plan of
Distribution.” |
Use of Proceeds |
Unless otherwise specified in a Prospectus Supplement, the Trust intends to invest the net
proceeds of an offering of Common Shares in accordance with its investment objectives and
policies. It is currently anticipated that the Trust will be able to invest
substantially all of the net proceeds of an offering of Common Shares in
accordance with its investment objectives and policies within three months
after the receipt of such proceeds. Pending such investment, it is
anticipated that the proceeds will be invested in cash, cash equivalents or other securities, including U.S. Government securities or high quality, short-term debt securities. The Trust
may also use the proceeds for working capital purposes, including the payment of
distributions, interest and operating expenses, although the Trust currently
has no intent to issue Common Shares primarily for these
purposes. |
Investment Objectives |
Please refer to the section of the Trust’s most recent annual report on Form N-CSR entitled “Investment Objective,” which is incorporated by reference herein, for a discussion of the
Trust’s investment objectives. |
Investment Strategies |
Please refer to the section of the Trust’s most recent annual report on Form N-CSR entitled “Principal Investment Strategies,” which is incorporated by reference herein, for a discussion
of the Trust’s investment strategies. |
Investment Policies |
Under normal market conditions:The Trust invests at least 80%
of its Managed Assets in taxable municipal securities, including
BABs, and other investment grade, income generating debt
securities, including debt instruments issued by non-profit entities (such as entities related to healthcare, higher education and housing), municipal conduits, project finance
corporations, and tax-exempt municipal securities.The Trust will not invest more than 25%
of its Managed Assets in municipal securities in any one state of origin.The
Trust will invest at least 50% of its Managed Assets in taxable municipal
securities.Under normal market conditions, the Trust invests at least 80% of its Managed Assets in securities that, at the time
of investment, are investment grade quality.Please refer to the section of
the Trust’s most
recent annual report on Form N-CSR
entitled “Portfolio Composition,” which is incorporated by
reference herein, for further information regarding these and other investment policies of the Trust. |
Special Tax Considerations |
The Trust has elected to be treated as, and intends to continue to qualify for taxation as, a
regulated investment company (“RIC”) for U.S. federal income tax purposes. For
so long as the Trust so qualifies, it will generally not be subject to U.S.
federal income tax on income or gains that it timely distributes to its
shareholders. The Trust primarily invests in taxable |
|
Although the use of Financial Leverage by the Trust may create an opportunity for increased
total return for the Common Shares, it also results in additional risks and can magnify the
effect of any losses. Financial Leverage involves risks and special
considerations for shareholders, including the likelihood of greater
volatility of net asset value and market price of, and dividends on, the
Common Shares. To the extent the Trust increases its amount of Financial
Leverage outstanding, it will be more exposed to these risks. The cost of Financial Leverage, including the portion of the investment advisory fee attributable to the assets
purchased with the proceeds of Financial Leverage, is borne by holders of Common Shares
(“Common Shareholders”). To the extent the Trust increases its
amount of Financial Leverage outstanding, the Trust’s annual expenses
as a percentage of net assets attributable to Common Shares will
increase. |
|
The Trust’s use of leverage through reverse repurchase agreements, dollar rolls and
economically similar transactions will be included when calculating the Trust’s
Financial Leverage and therefore will be limited by the Trust’s maximum
overall Financial Leverage levels approved by the Board of Trustees and may
be further limited by the applicable requirements of the Securities and
Exchange Commission (the “SEC”) discussed herein. |
|
In addition, the Trust may engage in certain derivatives transactions that have economic
characteristics similar to leverage. The Trust’s obligations under such transactions
will not be considered indebtedness for purposes of the 1940 Act and will not
be included in calculating the aggregate amount of the Trust’s
Financial Leverage, but the Trust’s use of such transactions may be
limited by the applicable requirements of the SEC. |
|
The Adviser anticipates that the use of Financial Leverage may result in higher total return to
the Common Shareholders over time; however, there can be no assurance that the
Adviser’s expectations will be realized or that a leveraging strategy
will be successful in any particular time period. Use of Financial Leverage
creates an opportunity for increased income and capital appreciation but, at
the same time, creates special risks. The costs associated with the issuance
or use of Financial Leverage will be borne by Common Shareholders, which will
result in a reduction of net asset value of the Common Shares. The fees paid to the Adviser
will be calculated on the basis of the Trust’s Managed Assets,
including proceeds from Financial Leverage, so the fees paid to the Adviser
will be higher when Financial Leverage is utilized. |
|
Common Shareholders bear the portion of the investment advisory fee attributable to the
assets purchased with the proceeds of Financial Leverage, which means that Common
Shareholders effectively bear the entire advisory fee. The maximum level of
and types of Financial Leverage used by the Trust will be approved by the
Board of Trustees. There can be no assurance that a leveraging strategy will
be utilized or, if utilized, will be successful. See “Use of
Leverage.” |
During periods in which the Adviser believes that economic, financial, market or political
conditions make it advisable to maintain a temporary defensive posture (a “temporary
defensive period”), or in order to keep the Trust’s cash fully
invested, including the period during which the net proceeds of the offering
of Common Shares are being invested, the Trust may, without limitation, hold
cash or invest its assets in money market instruments and repurchase
agreements in respect of those instruments. The Trust may not achieve its
investment objectives during a temporary defensive period or be able to sustain its
historical distribution levels. See “The Trust’s
Investments—Temporary Defensive Investments.” | |
Distributions |
The Trust intends to pay substantially all of its net investment income to Common Shareholders through monthly distributions. In addition, the Trust intends to distribute any net
long-term capital gains to Common Shareholders at least annually. The Trust expects that
dividends paid on the Common Shares will consist primarily of (i) investment
company taxable income, which includes, among other things, ordinary income,
net short-term capital gain and income from certain hedging and interest rate
transactions, and (ii) net capital gain (which is the excess of net long-term
capital gain over net short-term capital loss). Distributions may be paid by
the Trust from any permitted source and, from time to time, all or a portion
of a distribution may be a return of capital. The Trust cannot assure you, however, as to what percentage of the dividends paid on the Common Shares, if any, will consist of net
capital gain, which is taxed at reduced rates for non-corporate investors. The
distributions paid by the Trust for any particular month may be more than the
amount of net investment income |
|
from that monthly period. As a result, all or a portion of a distribution may be a return of
capital, which is in effect a partial return of the amount a Common Shareholder invested in
the Trust. For U.S. federal income tax purposes, a return of capital
distribution is generally not taxable up to the amount of the Common
Shareholder’s tax basis in their Common Shares and would reduce such
tax basis, and any amounts exceeding such basis will be treated as a gain
from the sale of their Common Shares. Although a return of capital may not be taxable, it
will generally increase the Common Shareholder’s potential gain, or
reduce the Common Shareholder’s potential loss, on any subsequent sale
or other disposition of Common Shares. Shareholders who periodically receive
the payment of a distribution consisting of a return of capital may be under
the impression that they are receiving net income or profits when they are
not. Shareholders should not assume that the source of a distribution from the Trust is net income or profit. Alternatively, in certain circumstances, the Trust may elect to retain income
or capital gain and pay income or excise tax on such undistributed amount, to the extent
that the Board of Trustees, in consultation with Trust management, determines
it to be in the best interest of shareholders to do so. During the
Trust’s fiscal year ended May 31, 2022, the Trust paid excise tax of
$0. See “Distributions” and “Tax Matters.” |
|
The Trust reserves the right to change its distribution policy and the basis for establishing the
rate of distributions at any time and may do so without prior notice to Common
Shareholders. |
|
If you hold your Common Shares in your own name or if you hold your Common Shares with
a brokerage firm that participates in the Trust’s Dividend Reinvestment Plan (the
“Plan”), unless you elect to receive cash, all dividends and
distributions that are declared by the Trust will be automatically reinvested
in additional Common Shares of the Trust pursuant to the Plan. If you hold
your Common Shares with a brokerage firm that does not participate in the
Plan, you will not be able to participate in the Plan and any dividend reinvestment may be
effected on different terms than those described above. Consult your
financial advisor for more information. See “Dividend Reinvestment
Plan.” |
Listing and Symbol |
The Trust’s currently outstanding Common Shares are, and the Common Shares offered by
this Prospectus, will be, subject to notice of issuance, listed on the New York Stock
Exchange (the “NYSE”) under the symbol “GBAB.” The
net asset value of the Common Shares at the close of business on September
13, 2022 was $17.05 per share, and the last reported sale price of the Common
Shares on the NYSE on such date was $17.54 per share, representing a premium
to net asset value per share of 2.87%. See “Market and Net Asset Value
Information.” |
Special Risk Considerations |
An investment in Common Shares of the Trust involves special risk considerations. Please
refer to the section of
the Trust’s most recent annual report on Form N-CSR entitled “Principal Risks of the Trust,” which is incorporated by reference herein, for a discussion of the
associated risks of investment in the Trust. You should carefully consider these risks
together with all of the other information contained in this Prospectus
before making a decision to purchase the Trust’s Common
Shares. |
The Trust’s Agreement and Declaration of Trust (the “Declaration of Trust”) and the Trust’s
Bylaws, as each may be amended and/or restated from time to time, (collectively, the
“Governing Documents”) include provisions that could limit the
ability of other entities or persons to acquire control of the Trust or
convert the Trust to an open-end fund. These provisions could have the effect
of depriving the Common Shareholders of opportunities to sell their Common
Shares at a premium over the then-current market price of the Common Shares.
See “Anti-Takeover and Other Provisions in the Trust’s Governing Documents.” | |
Custodian, Administrator, Transfer Agent and Dividend Disbursing Agent |
The Bank of New York Mellon serves as the custodian of the Trust’s assets pursuant to a
custody agreement. Under the custody agreement, the custodian holds the Trust’s
assets in compliance with the 1940 Act. For its services, the custodian
receives a monthly fee based upon, among other things, the average value of
the total assets of the Trust, plus certain charges for securities
transactions. |
|
Computershare Trust Company, N.A. serves as the Trust’s dividend disbursing agent and agent
under the Trust’s Dividend Reinvestment Plan (the “Plan Agent”) and
Computershare Inc. serves as transfer agent and registrar with respect to the
Common Shares of the Trust. |
|
MUFG Investor Services (US) LLC (“MUFG”), serves as the Trust’s administrator and fund |
|
accounting agent. Pursuant to an administration agreement, MUFG provides certain administrative services to the Trust. Pursuant to a fund accounting agreement, MUFG is
responsible for maintaining the books and records of the Trust’s securities and
cash. |
Shareholder Transaction Expenses |
|
Sales load (as a percentage of offering price)(1) |
—% |
Offering expenses borne by the Trust (as a percentage of offering price)(1)(2) |
0.60% |
Dividend Reinvestment Plan
fees(3) |
None |
|
As a Percentage of Net Assets Attributable to Common Shares(4)
|
Annual Expenses |
|
Management fee(5)
|
0.82% |
Acquired fund fees and
expenses(6) |
0.20% |
Interest expense(7)
|
0.31% |
Other expenses(8)
|
0.21% |
Total annual expenses(9)
|
1.54% |
1 Year |
3 Years |
5 Years |
10 Years |
$22 |
$55 |
$90 |
$189 |
Per Share Data: |
Year Ended May 31, 2022 |
Year Ended May 31, 2021 |
Year Ended May 31, 2020 |
Year Ended May 31, 2019 |
Year Ended May 31, 2018 |
Net asset value, beginning of period |
$22.80 |
$22.09 |
$22.71 |
$22.69 |
$23.30 |
Income from investment operations: |
|
|
|
|
|
Net investment income(a) |
1.21 |
1.19 |
1.27 |
1.30 |
1.48 |
Net gain (loss) on investments (realized and unrealized) |
(4.15) |
1.03 |
(0.38 ) |
0.23 |
(0.58) |
Total from investment operations |
(2.94) |
2.22 |
0.89 |
1.53 |
0.90 |
Common shares’ offering expense charged to paid-in capital |
— |
— |
— |
— |
— |
Less distributions from: |
|
|
|
|
|
Net investment income |
(1.51) |
(1.38) |
(1.51) |
(1.43) |
(1.35) |
Capital gains |
— |
(0.13) |
— |
(0.08) |
(0.16 |
Return of capital |
(0.17) |
(0.00)* |
— |
— |
— |
Total distributions to shareholders |
(1.51) |
(1.51) |
(1.51) |
(1.51) |
(1.51) |
Net asset value, end of period |
$18.35 |
$22.80 |
$22.09 |
$22.71 |
$22.69 |
Market value, end of period |
$19.45 |
$24.22 |
$23.20 |
$23.38 |
$21.44 |
Total Return(b) |
|
|
|
|
|
Net asset value |
(13.81)%(f)
|
10.30% |
3.86% |
7.11% |
3.93 |
Market value |
(13.96)% |
11.43% |
6.03% |
16.81% |
(1.23) |
Ratios/Supplemental Data: |
|
|
|
|
|
Net assets, end of period (in thousands) |
$401,122 |
$472,691 |
$414,168 |
$395,716 |
$395,221 |
Ratio to average net assets of: |
|
|
|
|
|
Total expenses, including interest expense(c)(e) |
1.34% |
1,27% |
1.65% |
1.68% |
1.65 |
Net investment income, including interest expense |
5.52% |
5.22% |
5.61% |
5.82% |
6.42 |
Portfolio turnover rate |
36% |
33% |
25% |
6% |
8% |
Senior Indebtedness: |
|
|
|
|
|
Borrowings – committed facility agreement (in thousands) |
— |
$97,360 |
$10,510 |
$44,510 |
$44,510 |
Asset Coverage per $1,000 of indebtedness(d) |
— |
$5,855 |
$40,409 |
$9,891 |
$9,879 |
2022 |
2021 |
2020 |
2019 |
2018 |
1.04% |
1.01% |
0.96% |
0.95% |
0.99% |
Per Share Data: |
Year Ended May 31, 2017 |
Year Ended May 31, 2016 |
Year Ended May 31, 2015 |
Year Ended May 31, 2014 |
Year Ended May 31, 2013 |
Net asset value, beginning of period |
$23.30 |
$23.35 |
$23.26 |
$23.61 |
$23.49 |
Income from investment operations: |
|
|
|
|
|
Net investment income(a) |
1.59 |
1.48 |
1.48 |
1.63 |
1.65 |
Net gain (loss) on investments (realized and unrealized) |
(0.04) |
0.13 |
0.27 |
(0.32) |
0.07 |
Total from investment operations |
1.55 |
1.61 |
1.75 |
1.31 |
1.72 |
Common shares’ offering expense charged to paid-in capital |
— |
— |
— |
— |
— |
Less distributions from: |
|
|
|
|
|
Net investment income |
(1.55) |
(1.64) |
(1.48) |
(1.60) |
(1.60) |
Capital gains |
— |
(0.02) |
(0.18) |
(0.06) |
— |
Total distributions to shareholders |
(1.55) |
(1.66) |
(1.66) |
(1.66) |
(1.60) |
Net asset value, end of period |
$23.30 |
$23.30 |
$23.35 |
$23.26 |
$23.61 |
Market value, end of period |
$23.23 |
$22.28 |
$21.64 |
$21.69 |
$22.7 |
Total Return(b) |
|
|
|
|
|
Net asset value |
6.81% |
7.25% |
7.64% |
6.15% |
7.48% |
Market value |
11.62% |
10.95% |
7.52% |
3.54% |
8.27% |
Ratios/Supplemental Data: |
|
|
|
|
|
Net assets, end of period (in thousands) |
$405,780 |
$405,820 |
$406,668 |
$405,039 |
$411,135 |
Ratio to average net assets of: |
|
|
|
|
|
Total expenses, including interest expense(c)(h) |
1.54 % |
1.38 % |
1.32 % |
1.35 % |
1.38 % |
Net investment income, including interest expense |
6.80 % |
6.47 % |
6.26 % |
7.37 % |
6.99 % |
Portfolio turnover rate |
6 % |
7 % |
11 % |
10 % |
12 % |
Senior Indebtedness: |
|
|
|
|
|
Borrowings – committed facility agreement (in thousands) |
$47,509 |
$61,710 |
$35,510 |
$30,964 |
$44,213 |
Asset Coverage per $1,000 of indebtedness(d) |
$9,541 |
$7,576 |
$12,452 |
$14,081 |
$10,299 |
|
Market Price |
Net Asset Value per Common Share on Date of Market Price High and Low(1)
|
Premium/(Discount) on Date of Market Price High and Low(2)
| |||
Fiscal Quarter Ended |
High |
Low |
High |
Low |
High |
Low |
August 31, 2022 |
$19.29 |
$17.01 |
$18.29 |
$17.36 |
5.47% |
(2.02)% |
May 31, 2022 |
21.16 |
18.06 |
21.51 |
18.18 |
(1.63) |
(0.66) |
February 28, 2022 |
23.73 |
20.00 |
23.04 |
21.17 |
2.99 |
(5.53) |
November 30, 2021 |
25.25 |
23.29 |
23.52 |
22.75 |
7.36 |
2.37 |
August 31, 2021 |
24.89 |
24.30 |
23.12 |
23.36 |
7.66 |
4.02 |
May 31, 2021 |
24.30 |
22.62 |
22.61 |
22.03 |
7.47 |
2.68 |
February 28, 2021 |
25.68 |
23.88 |
23.37 |
22.49 |
9.88 |
6.18 |
November 30, 2020 |
25.69 |
23.57 |
23.62 |
22.82 |
13.57 |
3.29 |
August 31, 2020 |
24.40 |
22.53 |
22.94 |
22.47 |
6.36 |
0.27 |
Title of Class |
Amount Authorized |
Amount Held by Trust for its own Account |
Amount
Outstanding Exclusive of Amounts
held by Trust |
Common Shares of Beneficial Interest, par value $0.01 per share |
Unlimited |
- |
22,213,862 |
Board
Meetings |
Executive
Committee
Meetings |
Audit
Committee
Meetings |
Nominating
and
Governance
Committee
Meetings |
Contracts
Review
Committee
Meetings |
Valuation
Oversight
Committee
Meetings |
8 |
0 |
6 |
3 |
1 |
4 |
Name of Trustee(1) |
Aggregate
Compensation
from the Trust |
Pension or
Retirement
Benefits Accrued
as Part of
Trust Expenses(2) |
Estimated
Annual Benefits
Upon
Retirement(2) |
Total
Compensation
from the Trust
and Trust
Complex
Paid to
Trustee(3) |
Independent Trustees | ||||
Randall C. Barnes |
$[•] |
[None] |
[None] |
$324,000 |
Angela Brock-Kyle |
$[•] |
[None] |
[None] |
$324,000 |
Thomas Lydon, Jr. |
$[•] |
[None] |
[None] |
$330,000 |
Ronald A. Nyberg |
$[•] |
[None] |
[None] |
$330,000 |
Sandra G. Sponem |
$[•] |
[None] |
[None] |
$374,000 |
Ronald E. Toupin, Jr. |
$[•] |
[None] |
[None] |
$418,000 |
Name of
Portfolio
Manager |
Number of Other Accounts
Managed and Assets by Account Type |
Number of Other Accounts Assets for
Which Advisory Fee is Performance-Based | ||||
Other
Registered
Investment
Companies |
Other
Pooled
Investment
Vehicles |
Other
Accounts |
Other
Registered
Investment
Companies |
Other Pooled
Investment
Vehicles |
Other
Accounts | |
B. Scott Minerd |
9 |
73 |
140 |
0 |
43 |
15 |
|
$13,454,498,593 |
$13,142,403,450 |
$165,379,442,715 |
$0 |
$9,100,551,269 |
$6,052,868,685 |
Anne B. Walsh |
16 |
6 |
105 |
0 |
3 |
2 |
|
$44,855,907,059 |
$3,396,075,180 |
$152,904,882,859 |
$0 |
$2,064,877,547 |
$786,158,709 |
Steven H.
Brown |
15 |
6 |
35 |
0 |
3 |
3 |
|
$43,468,956,782 |
$3,396,075,180 |
$17,950,992,422 |
$0 |
$2,064,877,547 |
$693,819,282 |
Allen Li |
2 |
0 |
1 |
0 |
0 |
0 |
|
$628,238,395 |
$0 |
$112,602,140 |
$0 |
$0 |
$0 |
Adam J. Bloch |
21 |
6 |
35 |
0 |
3 |
3 |
|
$43,652,610,049 |
$3,396,075,180 |
$17,950,992,422 |
$0 |
$2,064,877,547 |
$693,819,282 |
Evan
Serdensky |
1 |
0 |
0 |
0 |
0 |
0 |
|
$818,880,490 |
$0 |
$0 |
$0 |
$0 |
$0 |
Portfolio Manager |
|
B. Scott Minerd |
None |
Anne B. Walsh |
$100,001-$500,000 |
Steven H. Brown |
None |
Allen Li |
None
|
Adam J. Bloch |
None |
Evan Serdensky |
None |
|
Fiscal Year Ended May 31, | ||
|
2022 |
2021 |
2020 |
The Investment Adviser received
advisory fees of: |
$3,894,119 |
$3,477,659 |
$3,084,981 |
|
Fiscal Year Ended May 31, | ||
|
2022 |
2021(1) |
2020(1) |
GPIM received sub-advisory fees
of: |
$1,947,060 |
$1,768,830 |
$1,542,491 |
GPA received sub-advisory fees
of: |
$32,451 |
$— |
$— |
|
Fiscal Year Ended May 31, | ||
|
2022 |
2021 |
2020 |
MUFG received administration
fees of : |
$137,353 |
$126,941 |
$116,846 |
|
Fiscal Year Ended May 31, | ||
|
2022 |
2021 |
2020 |
MUFG received fund accounting
fees of: |
$149,610 |
$150,272 |
$143,893 |
Fiscal Year Ended May 31: |
All Brokers |
Affiliated Brokers |
2022 |
$38,978 |
$0 |
2021 |
$2,938 |
$0 |
2020 |
$44,752 |
$0 |
Fiscal Year Ended May 31, 2022 Percentages: |
|
Percentage of aggregate brokerage commissions paid to affiliated
broker |
0% |
Percentage of aggregate dollar amount of transactions involving the payment of
commissions effected through affiliated broker |
0% |
(a) |
(i)(1) |
|
|
(i)(2) |
|
|
(ii)(1) |
|
|
(ii)(2) |
|
|
(ii)(3) |
|
(b) |
|
|
(c) |
|
Not applicable |
(d) |
|
Not applicable |
(e) |
|
|
(f) |
|
Not applicable |
(g) |
(i) |
|
|
(ii) |
|
|
(iii) |
|
(h) |
(i) |
|
|
(ii) |
|
|
(iii) |
Form of Second Amendment to Controlled Equity Offering℠ Sale Agreement among the Registrant, the
Investment Adviser and Cantor Fitzgerald & Co.(+) |
(i) |
|
Not applicable |
(j) |
(i) |
|
|
(ii) |
|
(k) |
(i)(1) |
|
|
(i)(2) |
|
|
(ii)(1) |
|
|
(ii)(2) |
|
|
(ii)(3) |
|
|
(iii)(1) |
|
|
(iii)(2) |
|
|
(iii)(3) |
|
|
(iv)(1) |
|
|
(iv)(2) |
|
|
(iv)(3) |
|
|
(iv)(4) |
|
|
(iv)(5) |
|
|
(iv)(6) |
|
(iv)(7) |
|
|
(v) |
|
|
(vi) |
|
|
(vii) |
|
(l) |
|
Opinion and Consent of Dechert LLP(+) |
(m) |
|
Not applicable |
(n) |
|
Consent of Independent Registered Public Accounting Firm(+) |
(o) |
|
Not applicable |
(p) |
|
|
(q) |
|
Not applicable |
(r) |
(i) |
|
|
(ii) |
|
(s) |
|
|
(t) |
|
|
(u) |
|
NYSE Listing Fees |
$[ ] |
SEC Registration Fees |
$[ ] |
Independent Registered Public Accounting Firm Fees |
$[ ] |
Legal Fees |
$[ ] |
FINRA Fees |
$[ ] |
Miscellaneous |
$[ ] |
Total |
$[ ] |
Title of Class |
Number of Record Shareholders
as of [•], 2022 |
Common shares of beneficial interest, par value $0.01 per share |
[•] |
GUGGENHEIM TAXABLE MUNICIPAL BOND & INVESTMENT GRADE DEBT TRUST |
By: |
/s/ Brian E. Binder |
|
Brian E. Binder President and Chief Executive Officer (Principal Executive Officer) |
|
/s/ Brian E. Binder |
* Randall C. Barnes Trustee |
Brian E. Binder President and Chief Executive Officer (Principal Executive Officer) |
|
|
|
/s/ James M. Howley |
* Angela-Brock Kyle Trustee |
James M. Howley Chief Financial Officer, Chief Accounting Officer and Treasurer (Principal Financial and Accounting Officer) |
|
|
|
/s/ Amy J. Lee |
* Thomas Lydon, Jr. Trustee |
Amy J. Lee Trustee, Vice President and Chief Legal Officer |
|
|
|
|
* Ronald A. Nyberg Trustee |
* Signed by Mark E. Mathiasen, pursuant to a power of attorney filed herewith. |
|
|
|
/s/ Mark E. Mathiasen |
* Sandra G. Sponem Trustee |
Mark E. Mathiasen Attorney-In-Fact |
|
|
|
|
* Ronald E. Toupin Jr. Trustee |
|
GUGGENHEIM FUNDS INVESTMENT ADVISORS, LLC |
By: |
/s/ Amy J. Lee |
|
Name: Amy J. Lee Title: Sr. Vice President & Secretary |
GUGGENHEIM PARTNERS ADVISORS, LLC |
By: |
/s/ Amy J. Lee |
|
Name: Amy J. Lee Title: Attorney-in-Fact |
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust |
By: |
/s/ Amy J. Lee |
|
Name: Amy J. Lee Title: Vice President and Chief Legal Officer |
GUGGENHEIM TAXABLE MUNICIPAL BOND & INVESTMENT GRADE DEBT TRUST,
as Borrower |
By: |
/s/ John L. Sullivan |
|
Name: John L. Sullivan Title: Chief Financial Officer |
SOCIÉTÉ GÉNÉRALE, NEW YORK BRANCH, as Lender |
By: |
/s/ Julien Gimbrere |
|
Name: Julien Gimbrere Title: MD |
SOCIÉTÉ GÉNÉRALE as Agent |
By: |
/s/ Julien Gimbrere |
|
Name: Julien Gimbrere Title: MD |
/s/ Randall C. Barnes |
|
Randall C. Barnes Trustee |
|
|
|
/s/ Angela Brock-Kyle |
|
Angela Brock-Kyle Trustee |
|
|
|
/s/ Thomas F. Lydon, Jr. |
|
Thomas F. Lydon, Jr. Trustee |
|
|
|
/s/ Ronald A. Nyberg |
|
Ronald A. Nyberg Trustee |
|
|
|
/s/ Sandra G. Sponem |
|
Sandra G. Sponem Trustee |
|
|
|
/s/ Ronald E. Toupin, Jr. |
|
Ronald E. Toupin, Jr. Trustee |
|
/s/ Amy. J. Lee |
|
Amy J. Lee |
|
|
Page |
4 | |
5 | |
6 | |
7 | |
7 | |
7 | |
7 | |
8 |
|
deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the1933 Act. See
“Plan of Distribution” in this Prospectus Supplement. |
|
The Common Shares may not be sold through agents, underwriters or dealers without delivery
or deemed delivery of the Prospectus and this Prospectus Supplement describing the method
and terms of the offering of Common Shares. |
|
Under the 1940 Act, the Trust may not sell Common Shares at a price below the then current
NAV per Common Share, after taking into account any commission or discount.
|
Risks |
See “Risks” beginning on page [•] of the accompanying Prospectus for a discussion of factors
you should consider carefully before deciding to invest in the Trust’s Common
Shares. |
Use of Proceeds |
The Trust intends to invest the net proceeds of the offering in accordance with its investment
objective and policies as stated in the accompanying Prospectus. It is currently
anticipated that the Trust will be able to invest substantially all of the
net proceeds of the offering in accordance with its investment objective and
policies within three months after the receipt of such proceeds. Pending such
investment, it is anticipated that the proceeds will be invested in cash,
cash equivalents or other securities, including U.S. government securities or high quality, short-term debt securities. The Trust may also use the proceeds for working capital purposes,
including the payment of distributions, interest and operating expenses, although the Trust
currently has no intent to issue Common Shares primarily for these
purposes. |
Shareholder Transaction Expenses |
|
Sales load (as a percentage of offering price)(1) |
[•]% |
Offering expenses borne by the Trust (as a percentage of offering price)(2) |
[•]% |
Dividend Reinvestment Plan
fees(3) |
None |
Annual Expenses |
As a Percentage of Net Assets Attributable to Common
Shares(4) |
Management fee(5)
|
[ ]% |
Acquired fund fees and
expenses(6) |
[ ]% |
Interest expense(7)
|
[ ]% |
Other expenses(8)
|
[ ]% |
Total annual expenses(9)
|
[ ]% |
1 Year |
3 Years |
5 Years |
10 Years |
$[•] |
$[•] |
$[•] |
$[•] |
|
Actual (audited) |
As
Adjusted (unaudited) |
As Further
Adjusted (unaudited) |
Short-Term Debt: |
|
|
|
Borrowings and Reverse Repurchase Agreements |
$[•]
|
$[•]
|
$[•] |
Common Shareholder’s Equity: |
|
|
|
Common shares of beneficial interest, par value $0.01 per share; unlimited shares authorized, [•] shares issued and outstanding (actual), [•] shares
issued and outstanding (as adjusted), and [•] shares issued and outstanding
(as further adjusted) |
$[•]
|
$[•]
|
$[•] |
Additional paid-in capital |
$[•] |
$[•] |
$[•] |
Total distributable earnings (loss) |
$[•]
|
$[•]
|
$[•] |
Net assets |
$[•] |
$[•] |
$[•] |